749 related articles for article (PubMed ID: 29501212)
1. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.
Blair AB; Murphy A
Curr Probl Cancer; 2018; 42(1):49-58. PubMed ID: 29501212
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic Approaches to Biliary Cancer.
Shah UA; Nandikolla AG; Rajdev L
Curr Treat Options Oncol; 2017 Jul; 18(7):44. PubMed ID: 28660602
[TBL] [Abstract][Full Text] [Related]
3. Biliary Tract Cancer: Implicated Immune-Mediated Pathways and Their Associated Potential Targets.
Tariq NU; Vogel A; McNamara MG; Valle JW
Oncol Res Treat; 2018; 41(5):298-304. PubMed ID: 29705791
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of biliary tract cancer.
Chai Y
Tumour Biol; 2016 Mar; 37(3):2817-21. PubMed ID: 26729196
[TBL] [Abstract][Full Text] [Related]
5. [Advance in immunotherapy on biliary tract cancers].
Liu LG; Zhang YJ; Wang XA; Liu YB
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):156-160. PubMed ID: 33378809
[TBL] [Abstract][Full Text] [Related]
6. Novel immunotherapy strategies for hepatobiliary cancers.
DeLeon TT; Zhou Y; Nagalo BM; Yokoda RT; Ahn DH; Ramanathan RK; Salomao MA; Aqel BA; Mahipal A; Bekaii-Saab TS; Borad MJ
Immunotherapy; 2018 Sep; 10(12):1077-1091. PubMed ID: 30185133
[TBL] [Abstract][Full Text] [Related]
7. Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers.
Conci S; Catalano G; Roman D; Zecchetto C; Lucin E; De Bellis M; Tripepi M; Guglielmi A; Milella M; Ruzzenente A
Int J Med Sci; 2023; 20(7):858-869. PubMed ID: 37324191
[TBL] [Abstract][Full Text] [Related]
8. [The revolution of immuno-oncology therapy: review of immune checkpoint inhibitors efficacy].
Dubois M; Ardin C; André F; Scherpereel A; Mortier L
Med Sci (Paris); 2019 Dec; 35(12):937-945. PubMed ID: 31903897
[TBL] [Abstract][Full Text] [Related]
9. Current Progress in Immunotherapy for the Treatment of Biliary Cancers.
Pauff JM; Goff LW
J Gastrointest Cancer; 2016 Dec; 47(4):351-357. PubMed ID: 27538880
[TBL] [Abstract][Full Text] [Related]
10. Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma.
Saeed A; Park R; Al-Jumayli M; Al-Rajabi R; Sun W
Clin Colorectal Cancer; 2019 Jun; 18(2):81-90. PubMed ID: 30905548
[TBL] [Abstract][Full Text] [Related]
11. Current status of immunotherapy for the treatment of biliary tract cancer.
Takahashi R; Yoshitomi M; Yutani S; Shirahama T; Noguchi M; Yamada A; Itoh K; Sasada T
Hum Vaccin Immunother; 2013 May; 9(5):1069-72. PubMed ID: 23376808
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in ovarian cancer.
Krishnan V; Berek JS; Dorigo O
Curr Probl Cancer; 2017; 41(1):48-63. PubMed ID: 28169004
[TBL] [Abstract][Full Text] [Related]
13. The State of Immunotherapy in Hepatobiliary Cancers.
Ilyas FZ; Beane JD; Pawlik TM
Cells; 2021 Aug; 10(8):. PubMed ID: 34440865
[TBL] [Abstract][Full Text] [Related]
14. Current and emerging immunotherapeutic approaches for biliary tract cancers.
Yuan ZG; Zeng TM; Tao CJ
Hepatobiliary Pancreat Dis Int; 2022 Oct; 21(5):440-449. PubMed ID: 36115807
[TBL] [Abstract][Full Text] [Related]
15. Nivolumab: an investigational agent for the treatment of biliary tract cancer.
Di Federico A; Rizzo A; Ricci AD; Frega G; Palloni A; Tavolari S; Brandi G
Expert Opin Investig Drugs; 2021 Apr; 30(4):325-332. PubMed ID: 33307866
[No Abstract] [Full Text] [Related]
16. The state of therapy modalities in clinic for biliary tract cancer.
Chen W; Hu Z; Song J; Wu Y; Zhang B; Zhang L
Front Biosci (Landmark Ed); 2022 Jun; 27(6):185. PubMed ID: 35748261
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy in Biliary Tract Cancers: Where Are We?
Kalyan A; Khosla H; Kim RD
Curr Oncol Rep; 2022 Dec; 24(12):1821-1828. PubMed ID: 36192517
[TBL] [Abstract][Full Text] [Related]
18. Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation.
Athauda A; Fong C; Lau DK; Javle M; Abou-Alfa GK; Morizane C; Steward K; Chau I
Cancer Treat Rev; 2020 Jun; 86():101998. PubMed ID: 32203843
[TBL] [Abstract][Full Text] [Related]
19. Recent advances of immunotherapy for biliary tract cancer.
Rizzo A; Ricci AD; Brandi G
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):527-536. PubMed ID: 33215952
[No Abstract] [Full Text] [Related]
20. Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma).
Jakubowski CD; Azad NS
Chin Clin Oncol; 2020 Feb; 9(1):2. PubMed ID: 32008328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]